Case Report
Published on 02 Sep 2022
Low-dose PD-1 inhibitor combined with lenvatinib for preemptive treatment of recurrence after liver transplantation for hepatocellular carcinoma: Case report and literature review
in Cancer Immunity and Immunotherapy
- 2,542 views
- 6 citations